Corvus Pharmaceuticals, Inc.

CRVS·NASDAQ·$12.83Share Price as of 11/2·$1BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/12/26 10-QQ3 ended 09/30/2511/04/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report08/06/26 8-KCurrent report07/22/26 8-KCurrent report06/12/26 8-KCurrent report05/14/26 8-KCurrent report05/07/26

Prospectuses and Registrations

S-8Registration of securities for employees05/07/26 424B5Prospectus supplement03/13/26 S-3ASRAutomatic shelf registration03/13/26 424B5Prospectus supplement01/23/26 S-3MEFProspectus / registration01/21/26

Proxies

DEF 14ADefinitive proxy04/24/26 DEFA14AAdditional proxy materials04/24/26 DEF 14ADefinitive proxy04/25/25 DEFA14AAdditional proxy materials04/25/25 DEF 14ADefinitive proxy04/26/24

Ownership

SC 13G/ABeneficial ownership (amended)07/27/26 Form 4Insider transaction06/15/26 Form 4Insider transaction06/15/26 Form 4Insider transaction06/15/26 Form 4Insider transaction06/15/26

Other

EFFECTRequest for effectiveness08/15/24 CORRESPCorrespondence with the SEC08/13/24 UPLOADLetter from the SEC08/13/24 EFFECTRequest for effectiveness05/08/23 CORRESPCorrespondence with the SEC05/04/23